fda bpc-157 warning not approved drug Compounding Panel Backs Peptides for the 503A Bulks List, Against Reviewers' Recommendations TLDR: BPC-157 has not Catalog-Ref: 16516 Format:Lyophilized Powder

fda bpc-157 warning not approved drug Compounding Panel Backs Peptides for the 503A Bulks List, Against Reviewers' Recommendations TLDR: BPC-157 has not Catalog-Ref: 16516 Format:Lyophilized Powder

TLDR: BPC-157 has not been proven to cause cancer. But it has also not been proven safe in people with active cancer, recent cancer, premalignant conditions, suspicious lesions, or high recurrence risk.

A diagnostic-use formulation (0.05 mg base per ampule, for evaluating the pituitary's capacity to secrete growth hormone) was approved December 28, 1990 under NDA 19-863

Catalog-Ref: 16516

Format:Lyophilized Powder

Reproductive outcomes and impact on offspring are long-term data gaps